judy h. chou , ph.d. 周慧泉博士 vice president, research & development, tanvex ...

1

Judy H. Chou, Ph.D. 周周周周周 Vice President, Research & Development, Tanvex Biologics Inc. Vice President, Research & Development, La Jolla Biologics Inc. GIBMS SEMINAR 周周周周周周周 Graduate Institute of BioMedical Friday, December 06, 2013 15:10 PM Engineering Building 6 th Floor, Second Chamber Development of Protein Therapeutics Invited By : Dr. Jim-Tong Horng( 洪洪洪洪洪 )

Upload: suchi

Post on 17-Feb-2016

222 views

Category:

Documents

18 download

Report

Download

Embed Size (px):

DESCRIPTION

GIBMS SEMINAR. Judy H. Chou , Ph.D. 周慧泉博士 Vice President, Research & Development, Tanvex Biologics Inc. Vice President, Research & Development, La Jolla Biologics Inc. Development of Protein Therapeutics. Friday, December 06, 2013 15:10 PM - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Judy H. Chou , Ph.D. 周慧泉博士 Vice President, Research & Development, Tanvex Biologics Inc

Judy H. Chou, Ph.D. 周慧泉博士

Vice President, Research & Development, Tanvex Biologics Inc.

Vice President, Research & Development, La Jolla Biologics Inc.

GIBMS SEMINAR

生物醫學研究所Graduate Institute

of BioMedical Sciences

Friday, December 06, 2013 15:10 PMEngineering Building 6th Floor, Second Chamber

Development of Protein Therapeutics

Invited By : Dr. Jim-Tong Horng(洪錦堂教授 )

Biologics and Biosimilars - EHR Optimization€¦ · Biologics and Biosimilars ... •Current FDA Activity around Biologics and Biosimilars •State Regulatory Activity –Biologic

Subsequent Entry Biologics - Ontario Rheumatologyontariorheum.ca/images/uploads/content_documents/SEBs_Revers.pdf · subsequent entry biologics • Provide a summary of biologics

Fonaments Biologics

Biologics: Pharmacokinetics and Drug Developmentdmsc2.dmsc.moph.go.th/webroot/drug/km/lab_other/Biologics...1 Biologics: Pharmacokinetics and Drug Development Thomayant Prueksaritanont,

CHOU ASSOCIATES FUND CHOU ASIA FUND CHOU ...choufunds.com/pdf/AR 2017 EN.pdfStatements of Cash Flows 28 Schedule of Investments 29 Discussion of Financial Risk Management 30-31 Chou

TANVEX BIOPHARMA, INC. Annual Report (EN).pdf · tanvex biopharma, inc. tel: + 886-2-2701-0518 address: 13f-1, no. 376, sec. 4, ren’ai rd., da’an dist., taipei city 106, taiwan

Cmc biologics pathway_draft8

Biologics Manual (US)

PRP Biologics 2

ERIC - DOCUMENT RESUME Chou, Chien; Chou, Jung; Tyan, Nay … · 2013. 8. 2. · Chien Chou Jung Chou Institute of Communication Studies National Chiao Tung University. 1001 Ta-Hsueh

Ae biologics (net)

Biologics Reporting

Chapter 16 - Biologics

CRUCIFÈRES (CHOU, CHOU-FLEUR, RADIS, RUTABAGA .. . ) 8.1-8 · 2014. 10. 27. · 8.1 Tache bactérienne; lésions sur des choux de Bruxelles. p. 105 CRUCIFÈRES (CHOU, CHOU-FLEUR,

Biocon Biologics · 2019-12-13 · Biocon Biologics India Limited, India Biocon Biologics Limited, UK Biocon Biologics Inc, USA Biocon Research Limited, India Biocon SDN BHD, Malaysia

USP Standards for Biologics Tina S. Morris, Ph.D., Vice President, Biologics & Biotechnology USP-NF Fouad Atouf, Ph.D., Director, Biologics & Biotechnology,

Bourgoin Biologics Market

Biologics Monograph

Biologics Data Entry

Biologics Patent Protection

Model Biologics Indications

Biologics - Biomet

Obviousness of Biologics Inventions: Strategies for ...media.straffordpub.com/products/obviousness-of-biologics-invention… · Obviousness of Biologics Inventions: Strategies for

for Biologics Drug

Biologics Agenda

Biologics Guidelines 2009

CHOU ASSOCIATES FUND CHOU ASIA FUND CHOU ...choufunds.com/pdf/SA08.pdf1 CHOU ASSOCIATES FUND August 15, 2008 Dear Unitholders of Chou Associates Fund, The net asset value (“NAVPU”

Culture des choux en Provence - Chambre d'agriculture ......Chou frisé vert Chou cabus rond blanc Choux de Bruxelles PRODUCTION DU CHOU EN PROVENCE Le chou est une plante résistant